Elevating Expectations: Vericiguat in Heart Failure with Reduced Ejection Fraction
Introduction: Heart failure (HF) with reduced ejection fraction (EF) poses high morbidity and mortality. Guidelines Directed Medical Therapy (GDMT) is essential, yet many patients experience significant symptoms. Vericiguat, a soluble guanylate cyclase stimulator, may serve as an adjunctive therapy...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of Pharmacy and Bioallied Sciences |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jpbs.jpbs_1392_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|